Dr. Kowalski is the Chief Medical Officer and Vice President of Medical/Regulatory Affairs at Viventia Biotechnologies Inc. His past experience includes basic science research on the molecular biology of HIV as well as clinical practice in Internal Medicine. Dr. Kowalski received his medical, graduate and postgraduate training at the University of Kansas, Duke University and Harvard University. Most recently, Dr. Kowalski has worked in the drug development industry as Senior Director of Medical Affairs and Statistical Services at AAIPharma where he gained Phase I through Phase IV clinical trial experience in a wide variety of therapeutic areas including Oncology, Infectious Diseases and Analgesics. He has also provided consultative services for protocol development, study design and NDA/PMA preparation.
|
